Next Article in Journal
Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers
Previous Article in Journal
Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)
 
 
Article

Article Versions Notes

Cancers 2022, 14(5), 1121; https://doi.org/10.3390/cancers14051121
Action Date Notes Link
article pdf uploaded. 22 February 2022 18:05 CET Version of Record https://www.mdpi.com/2072-6694/14/5/1121/pdf-vor
article xml file uploaded 23 February 2022 04:30 CET Original file -
article xml uploaded. 23 February 2022 04:30 CET Update https://www.mdpi.com/2072-6694/14/5/1121/xml
article pdf uploaded. 23 February 2022 04:30 CET Updated version of record https://www.mdpi.com/2072-6694/14/5/1121/pdf
article supplementary file uploaded. 23 February 2022 04:30 CET - https://www.mdpi.com/2072-6694/14/5/1121#supplementary
article html file updated 23 February 2022 04:31 CET Original file -
article html file updated 1 August 2022 02:08 CEST Update https://www.mdpi.com/2072-6694/14/5/1121/html
Back to TopTop